CN114288267A - Noble metal nanoparticles/silica nano-space capsule composite material and preparation method thereof - Google Patents
Noble metal nanoparticles/silica nano-space capsule composite material and preparation method thereof Download PDFInfo
- Publication number
- CN114288267A CN114288267A CN202111658271.2A CN202111658271A CN114288267A CN 114288267 A CN114288267 A CN 114288267A CN 202111658271 A CN202111658271 A CN 202111658271A CN 114288267 A CN114288267 A CN 114288267A
- Authority
- CN
- China
- Prior art keywords
- preparation
- aqueous solution
- shell
- nano
- composite material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 239000000377 silicon dioxide Substances 0.000 title claims abstract description 26
- 239000002131 composite material Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000002775 capsule Substances 0.000 title claims abstract description 13
- 229910000510 noble metal Inorganic materials 0.000 title claims description 18
- 239000002082 metal nanoparticle Substances 0.000 title claims description 12
- 239000002105 nanoparticle Substances 0.000 claims abstract description 36
- 239000011258 core-shell material Substances 0.000 claims abstract description 26
- 238000003756 stirring Methods 0.000 claims abstract description 24
- 239000010970 precious metal Substances 0.000 claims abstract description 22
- 239000003446 ligand Substances 0.000 claims abstract description 18
- 229910052709 silver Inorganic materials 0.000 claims abstract description 18
- 239000004332 silver Substances 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000006185 dispersion Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 13
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 13
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 12
- 239000004094 surface-active agent Substances 0.000 claims abstract description 12
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 10
- 239000010703 silicon Substances 0.000 claims abstract description 10
- 239000002086 nanomaterial Substances 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 7
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 5
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 5
- 239000002114 nanocomposite Substances 0.000 claims abstract description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 3
- 239000007864 aqueous solution Substances 0.000 claims description 22
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 10
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- HDFRDWFLWVCOGP-UHFFFAOYSA-N carbonothioic O,S-acid Chemical compound OC(S)=O HDFRDWFLWVCOGP-UHFFFAOYSA-N 0.000 claims description 8
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052737 gold Inorganic materials 0.000 claims description 6
- 239000010931 gold Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- LMJXSOYPAOSIPZ-UHFFFAOYSA-N 4-sulfanylbenzoic acid Chemical compound OC(=O)C1=CC=C(S)C=C1 LMJXSOYPAOSIPZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- XCRDQVBOVYWDPH-UHFFFAOYSA-N 2-(4-methylphenyl)sulfanylacetic acid Chemical compound CC1=CC=C(SCC(O)=O)C=C1 XCRDQVBOVYWDPH-UHFFFAOYSA-N 0.000 claims description 2
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 2
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 claims description 2
- UPYPTOCXMIWHSG-UHFFFAOYSA-N 1-dodecylsulfanyldodecane Chemical group CCCCCCCCCCCCSCCCCCCCCCCCC UPYPTOCXMIWHSG-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 239000012046 mixed solvent Substances 0.000 abstract 1
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 1
- 239000002088 nanocapsule Substances 0.000 description 10
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical group [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- -1 4-methylphenylthioethyl Chemical group 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000007626 photothermal therapy Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
Images
Landscapes
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
Abstract
本发明公开了一种贵金属纳米颗粒/二氧化硅纳米太空舱复合材料及其制备方法;该制备方法包括以下步骤:步骤1,将贵金属纳米颗粒分散在水中,加入硝酸银与还原剂反应,得到贵金属/银核壳纳米颗粒分散液;步骤2,将分散液滴入水/醇的混合溶剂中,在剧烈搅拌条件下加入两种配体、表面活性剂与氨水,两种配体分别为巯基羧酸配体和分子量大的聚丙烯酸;步骤3,继续加入硅源搅拌,得到太空舱形状的空心纳米复合材料。本发明制备方法简单,条件温和、形貌可控,得到表面具有开口的非对称囊状纳米结构,该材料组成具有生物兼容性和生物安全性,作为纳米药物载体具有很好的前景。
The invention discloses a precious metal nano-particle/silicon dioxide nano-space capsule composite material and a preparation method thereof; the preparation method comprises the following steps: Step 1, dispersing the precious metal nano-particles in water, adding silver nitrate and reacting with a reducing agent to obtain Precious metal/silver core-shell nanoparticle dispersion; step 2, drop the dispersion into a mixed solvent of water/alcohol, add two ligands, surfactant and ammonia water under vigorous stirring, and the two ligands are mercapto groups respectively Carboxylic acid ligand and polyacrylic acid with large molecular weight; step 3, continue to add silicon source and stir to obtain a hollow nanocomposite material in the shape of a space capsule. The preparation method of the invention is simple, the conditions are mild, and the shape is controllable, and the asymmetric sac-like nanostructure with openings on the surface is obtained.
Description
技术领域technical field
本发明属于纳米材料技术领域,具体涉及一种金属核壳纳米颗粒/二氧化硅太空舱状空心纳米复合材料及其制备方法。The invention belongs to the technical field of nanomaterials, and in particular relates to a metal core-shell nanoparticle/silicon dioxide capsule-shaped hollow nanocomposite material and a preparation method thereof.
背景技术Background technique
众所周知,基于等离子体纳米颗粒的非对称结构继承了贵金属独特的光学和物理特性(例如局部表面等离子体共振和光热效应),但也赋予了它们新的特性,例如高度几何不对称性,使得他们在许多重要领域具有重大意义,例如作为分子表面活性剂类似物的界面稳定剂、传感、递送载体、成像、纳米反应器、自驱动的纳米机器人和用于组装复杂结构的单元。然而, 迄今为止,大多数报道的结构是固体材料,不能为功能性客体分子负载提供足够的存储空间,大大限制了它们的扩展和进一步的实际应用。因此,合理设计和构建表面具有开口的非对称囊状纳米结构是一个很大的挑战。It is well known that asymmetric structures based on plasmonic nanoparticles inherit the unique optical and physical properties of noble metals (such as localized surface plasmon resonance and photothermal effects), but also endow them with new properties, such as high geometric asymmetry, which makes them ideal for Many important fields are of great interest, such as interfacial stabilizers as molecular surfactant analogs, sensing, delivery vehicles, imaging, nanoreactors, self-driven nanorobots, and cells for assembling complex structures. However, to date, most of the reported structures are solid materials that do not provide sufficient storage space for functional guest molecule loading, greatly limiting their expansion and further practical applications. Therefore, the rational design and construction of asymmetric saccular nanostructures with openings on the surface is a great challenge.
发明内容SUMMARY OF THE INVENTION
针对现有技术的不足,本发明的目的在于提供一种贵金属纳米颗粒/二氧化硅纳米太空舱复合材料及其制备方法。本发明制备方法简单,条件温和、形貌可控,得到表面具有开口的非对称囊状纳米结构,该材料组成具有生物兼容性和生物安全性,作为纳米药物载体具有很好的前景。In view of the deficiencies of the prior art, the purpose of the present invention is to provide a noble metal nanoparticle/silica nano-capsule composite material and a preparation method thereof. The preparation method of the invention is simple, the conditions are mild, and the shape is controllable, and the asymmetric sac-like nanostructure with openings on the surface is obtained.
本发明的技术方案具体介绍如下。The technical solutions of the present invention are specifically introduced as follows.
本发明提供一种贵金属纳米颗粒/二氧化硅纳米太空舱复合材料的制备方法,该复合The invention provides a preparation method of a precious metal nanoparticle/silica nanometer space capsule composite material.
材料整体上呈太空舱结构,其为表面具有开口的非对称囊状纳米结构,由呈海胆状刺型的头部以及和头部相连的开口的空心尾巴组成,其中头部为核壳结构,内核为贵金属纳米颗粒,外壳为银壳,空心尾巴采用纳米二氧化硅材质;其通过以下方法制得:The material has a space capsule structure as a whole, which is an asymmetric sac-like nanostructure with an opening on the surface, consisting of a sea urchin-like spine-shaped head and an open hollow tail connected to the head, wherein the head is a core-shell structure, The inner core is a precious metal nanoparticle, the outer shell is a silver shell, and the hollow tail is made of nano-silica; it is prepared by the following method:
步骤1,将贵金属纳米颗粒分散在水中,加入还原剂和硝酸银搅拌反应,反应结束后离心浓度,再进一步分散到水中,得到浓度在0.5-100μg/mL之间的贵金属/银核壳纳米颗粒分散液;Step 1: Disperse the precious metal nanoparticles in water, add a reducing agent and silver nitrate to stir the reaction, centrifuge the concentration after the reaction, and then further disperse into water to obtain precious metal/silver core-shell nanoparticles with a concentration between 0.5-100 μg/mL Dispersions;
步骤2,将贵金属/银核壳纳米颗粒分散液滴加到醇的水溶液中后,搅拌条件下加入配体水溶液、表面活性剂水溶液和氨水,加完后继续搅拌20-40min;其中配体由巯基羧酸和聚丙烯酸组成;Step 2: After adding the precious metal/silver core-shell nanoparticle dispersion dropwise to the alcohol aqueous solution, add ligand aqueous solution, surfactant aqueous solution and ammonia water under stirring condition, and continue to stir for 20-40min after adding; Composed of mercaptocarboxylic acid and polyacrylic acid;
步骤3,向步骤2所得溶液中加入硅源搅拌反应,得到太空舱状空心纳米复合材料。In step 3, a silicon source is added to the solution obtained in step 2, and a stirring reaction is performed to obtain a capsule-shaped hollow nanocomposite material.
优选的,步骤1中,贵金属纳米颗粒为金纳米颗粒,还原剂选自对苯二酚、柠檬酸钠或硼氢化钠中任一种;贵金属/银核壳纳米颗粒分散液的浓度在20-60μg/mL之间。Preferably, in step 1, the precious metal nanoparticles are gold nanoparticles, and the reducing agent is selected from any one of hydroquinone, sodium citrate or sodium borohydride; the concentration of the precious metal/silver core-shell nanoparticle dispersion is 20- between 60 μg/mL.
优选的,步骤2中,醇为甲醇、乙醇、异丙醇或丁二醇中的任一种;水和醇的体积比为1:1-1:10;贵金属/银核壳纳米颗粒分散液和醇的水溶液之间的体积比为1:1-1:10。Preferably, in step 2, the alcohol is any one of methanol, ethanol, isopropanol or butanediol; the volume ratio of water and alcohol is 1:1-1:10; the precious metal/silver core-shell nanoparticle dispersion liquid The volume ratio between the aqueous solution of alcohol and alcohol is 1:1-1:10.
优选的,步骤2中,配体中,巯基羧酸为巯基丙酸、4-巯基苯甲酸或4-甲基苯硫基乙Preferably, in step 2, in the ligand, the mercaptocarboxylic acid is mercaptopropionic acid, 4-mercaptobenzoic acid or 4-methylphenylthioethyl
酸,聚丙烯酸的重均分子量MW在 1000-10000之间;巯基羧酸水溶液浓度为1-50mmol/L,聚丙烯酸水溶液浓度为1-50 mmol/L,巯基羧酸水溶液和聚丙烯酸水溶液的体积比为1:1-10:1;贵金属/银核壳纳米颗粒分散液和配体水溶液的体积比为1:5-20:1;搅拌转速为 100-1000rpm。Acid, the weight average molecular weight MW of polyacrylic acid is between 1000-10000; the concentration of mercaptocarboxylic acid aqueous solution is 1-50 mmol/L, the concentration of polyacrylic acid aqueous solution is 1-50 mmol/L, the volume of mercaptocarboxylic acid aqueous solution and polyacrylic acid aqueous solution The ratio is 1:1-10:1; the volume ratio of the noble metal/silver core-shell nanoparticle dispersion liquid and the ligand aqueous solution is 1:5-20:1; the stirring speed is 100-1000rpm.
优选的,步骤2中,表面活性剂为十二烷基硫酸钠、十二烷基苯磺酸钠、聚乙烯吡Preferably, in step 2, the surfactant is sodium dodecyl sulfate, sodium dodecylbenzenesulfonate, polyvinylpyridine
咯烷酮、十六烷基三甲基溴化铵CTAB或十六烷基三甲基氯化铵CTAC中的任意一种;表面活性剂水溶液浓度为0.0001-2 g/ml。Any one of rolidone, cetyltrimethylammonium bromide CTAB or cetyltrimethylammonium chloride CTAC; the concentration of the surfactant aqueous solution is 0.0001-2 g/ml.
优选的,步骤3中,硅源选自硅源为四乙氧基硅烷、四甲氧基硅烷或正硅酸乙酯中Preferably, in step 3, the silicon source is selected from the group consisting of tetraethoxysilane, tetramethoxysilane or ethyl orthosilicate
的任意一种,搅拌转速为100-500 rpm, 搅拌时间为5-15 h。The stirring speed is 100-500 rpm, and the stirring time is 5-15 h.
优选的,表面活性剂水溶液、硅源、氨水的体积比为600:1:90-600:10:90。Preferably, the volume ratio of the aqueous surfactant solution, the silicon source, and the ammonia water is 600:1:90-600:10:90.
本发明还提供一种上述的制备方法制得的贵金属纳米颗粒/二氧化硅纳米太空舱复合材料,该复合材料整体上呈太空舱结构,其为表面具有开口的非对称囊状纳米结构,由呈海胆状刺型的头部以及和头部相连的开口的空心尾巴组成,其中头部为核壳结构,内核为贵金属纳米颗粒,外壳为银壳,空心尾巴采用纳米二氧化硅材质。The present invention also provides a precious metal nanoparticle/silicon dioxide nano-space capsule composite material prepared by the above-mentioned preparation method. The composite material has a space capsule structure as a whole, which is an asymmetric sac-shaped nano-structure with openings on the surface. It consists of a sea urchin-like spine-shaped head and an open hollow tail connected to the head. The head is a core-shell structure, the inner core is a precious metal nanoparticle, the outer shell is a silver shell, and the hollow tail is made of nano-silica.
优选的,复合材料的头部长度在40-130 nm之间,开口的空心尾巴的开口尺寸在Preferably, the length of the head of the composite material is between 40-130 nm, and the opening size of the open hollow tail is between
70-240 nm之间。Between 70-240 nm.
本发明进一步提供一种上述的复合材料在纳米药物载体方面的应用。The present invention further provides an application of the above-mentioned composite material in nano-drug carriers.
和现有技术相比,本发明的有益效果在于:Compared with the prior art, the beneficial effects of the present invention are:
1、本发明提供一种贵金属纳米颗粒/二氧化硅纳米太空舱复合材料,其为核壳结构与一个纳米二氧化硅太空舱连接的复合结构,核壳结构的内核为金纳米颗粒,外壳由银壳组成,通过控制配体用量,可以控制舱体的开口口径。1. The present invention provides a precious metal nanoparticle/silicon dioxide nano-capsule composite material, which is a composite structure in which a core-shell structure is connected with a nano-silica space capsule, the core of the core-shell structure is gold nanoparticles, and the outer shell is composed of It is composed of silver shell, and the opening diameter of the cabin can be controlled by controlling the amount of ligand.
2、本发明的复合材料中的组分都具备优异的生物兼容性和生物安全性,其中的核壳结构具有强的近红外吸收峰以及光热效应,适合用于癌症的光热治疗,而具有开口的舱体结构具有高的比表面积,低密度特征,高的药物负载量,因此本发明复合材料作为纳米药物载体具有很好的应用前景。2. The components in the composite material of the present invention have excellent biocompatibility and biosafety, and the core-shell structure has strong near-infrared absorption peaks and photothermal effects, which are suitable for photothermal therapy of cancer, and have The open cabin structure has high specific surface area, low density and high drug loading, so the composite material of the present invention has a good application prospect as a nano drug carrier.
附图说明Description of drawings
图1是本发明实施例1制备得到的金银核壳结构的透射电子显微镜(TEM)图。FIG. 1 is a transmission electron microscope (TEM) image of the gold-silver core-shell structure prepared in Example 1 of the present invention.
图2是本发明实施例1制备得到的金银核壳结构的XRD衍射图。FIG. 2 is the XRD diffraction pattern of the gold-silver core-shell structure prepared in Example 1 of the present invention.
图3是本发明实施例1制备得到的贵金属纳米颗粒/二氧化硅纳米太空舱复合材料的透射电子显微镜(TEM)图。FIG. 3 is a transmission electron microscope (TEM) image of the noble metal nanoparticles/silicon dioxide nano-capsule composite material prepared in Example 1 of the present invention.
图4是本发明实施例制备得到的贵金属纳米颗粒/二氧化硅纳米太空舱复合材料的扫描电子显微镜(SEM)图。FIG. 4 is a scanning electron microscope (SEM) image of the noble metal nanoparticles/silicon dioxide nano capsule composite material prepared in the embodiment of the present invention.
图5是本发明制备得到的贵金属纳米颗粒/二氧化硅纳米太空舱紫外可见吸收光谱图。Fig. 5 is the ultraviolet-visible absorption spectrum diagram of noble metal nanoparticles/silicon dioxide nano space capsule prepared by the present invention.
图6是本发明制备得到的具有不同空心直径的贵金属纳米颗粒/二氧化硅纳米太空舱的透射电子显微镜图。FIG. 6 is a transmission electron microscope image of noble metal nanoparticles/silicon dioxide nano capsules with different hollow diameters prepared by the present invention.
具体实施方式Detailed ways
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,以下结合实施例及附图对本发明作具体阐述。In order to make it easy to understand the technical means, creative features, achieved goals and effects of the present invention, the present invention is described in detail below with reference to the embodiments and the accompanying drawings.
实施例1Example 1
贵金属纳米颗粒/二氧化硅纳米太空舱纳米复合材料由以下方法制备而成:The noble metal nanoparticle/silica nanocapsule nanocomposite was prepared by the following methods:
步骤1,将2.0ml、浓度为5μg /ml的粒径在30-90nm左右的金纳米颗粒悬浮液加入小瓶,然后加入120μl、浓度为10mM的对苯二酚、和120μl、浓度为10mM的硝酸银,搅拌反应2h后,离心并浓缩进一步分散在400μl水中,得到金银核壳结构的纳米颗粒分散液;Step 1, add 2.0ml of gold nanoparticle suspension with a particle size of about 30-90nm at a concentration of 5μg/ml into a vial, then add 120μl of hydroquinone at a concentration of 10mM, and 120μl of nitric acid at a concentration of 10mM Silver, after stirring and reacting for 2 hours, centrifuged and concentrated to further disperse in 400 μl of water to obtain a gold-silver core-shell nanoparticle dispersion;
步骤2,将金银核壳结构的纳米颗粒分散液滴加在3 ml的体积比为4:1的异丙醇与水的混合溶液中,在转速为700rpm的搅拌条件下再加入25μl 浓度为5mM 4-甲基苯硫基乙酸溶液和25μl 浓度为 5mM聚丙烯酸溶液作为共同配体,然后加入600μl浓度为0.0015g/mL十六烷基三甲基溴化铵表面活性剂溶液和90μl 25wt%氨水,搅拌30 分钟。Step 2, drop the nanoparticle dispersion of gold-silver core-shell structure into 3 ml of a mixed solution of isopropanol and water with a volume ratio of 4:1, and then add 25 μl under stirring at a speed of 700 rpm. 5mM 4-methylphenylthioacetic acid solution and 25μl of 5mM polyacrylic acid solution as co-ligands, then 600μl of 0.0015g/mL cetyltrimethylammonium bromide surfactant solution and 90μl of 25wt% Ammonia, stir for 30 minutes.
步骤3 向步骤2的溶液中,加入1μl硅源TEOS,在300rpm的转速下搅拌12小时得到贵金属纳米颗粒/二氧化硅纳米太空舱复合材料。Step 3 To the solution of Step 2, add 1 μl of TEOS, a silicon source, and stir at 300 rpm for 12 hours to obtain a precious metal nanoparticle/silicon dioxide nanocapsule composite material.
本实施例中的贵金属纳米颗粒/二氧化硅纳米太空舱复合材料的形貌,如图1和2所示分别是获得的金银纳米颗粒的粒径分布参考,以及物相分析,证实了核壳结构的合成。图3和图4分别是制备得到的复合材料的透射与扫描电镜图,证实了该结构的形貌由一个贵金属头和一个空心尾巴连接组成;其头部直径大约100 nm,头部为核壳结构,空心尾巴的开口尺寸大约为150 nm, 空心尾巴由二氧化硅组成。图5是用紫外可见分光光度计测的紫外可见吸收图谱,其结果证实了包覆二氧化硅后不影响贵金属的紫外吸收结果。The morphology of the noble metal nanoparticle/silica nanocapsule composite material in this example, as shown in Figures 1 and 2, is the particle size distribution reference of the obtained gold and silver nanoparticles, and the phase analysis confirms that the core Synthesis of Shell Structures. Figures 3 and 4 are the transmission and scanning electron microscope images of the prepared composites, respectively, confirming that the morphology of the structure consists of a noble metal head and a hollow tail connected; the diameter of the head is about 100 nm, and the head is a core-shell Structure, the size of the opening of the hollow tail is about 150 nm, and the hollow tail is composed of silica. Figure 5 is the UV-Vis absorption spectrum measured by UV-Vis spectrophotometer, and the results confirm that the coating of silica does not affect the UV-absorbing results of precious metals.
实施例2:Example 2:
贵金属纳米颗粒/二氧化硅纳米太空舱复合材料由以下方法制备而成,该方法包括以下步骤:The noble metal nanoparticle/silica nanocapsule composite material is prepared by the following method, and the method includes the following steps:
步骤1,将2.0ml、浓度为5μg /ml的粒径在30-90nm左右的金纳米颗粒悬浮液加入小瓶,然后加入120μl、浓度为10mM的对苯二酚、和120μl、浓度为10mM的硝酸银,搅拌反应2h后,离心并浓缩进一步分散在400μl水中,得到金银核壳结构的纳米颗粒分散液;Step 1, add 2.0ml of gold nanoparticle suspension with a particle size of about 30-90nm at a concentration of 5μg/ml into a vial, then add 120μl of hydroquinone at a concentration of 10mM, and 120μl of nitric acid at a concentration of 10mM Silver, after stirring and reacting for 2 hours, centrifuged and concentrated to further disperse in 400 μl of water to obtain a gold-silver core-shell nanoparticle dispersion;
步骤2,将金银核壳结构的纳米颗粒分散液滴加在3 ml的体积比为4:1的异丙醇与水的混合溶液中,在转速为700rpm的搅拌条件下再加入25μl ,浓度为5mM 的4-巯基苯甲酸水溶液、和25μl浓度为1-50 mM mM 的聚丙烯酸水溶液作为共同配体,然后加入600μl十六烷基三甲基溴化铵表面活性剂溶液和90μl 25wt%氨水,搅拌30 分钟。Step 2, drop the gold-silver core-shell structure nanoparticle dispersion into 3 ml of a mixed solution of isopropanol and water with a volume ratio of 4:1, and then add 25 μl under stirring at a speed of 700 rpm. 5 mM 4-mercaptobenzoic acid in water, and 25 μl polyacrylic acid in water at a concentration of 1-50 mM mM as co-ligands, then 600 μl cetyltrimethylammonium bromide surfactant solution and 90 μl 25wt% ammonia , stir for 30 minutes.
步骤3:向步骤2得到的溶液中加入1μl硅源TEOS, 在300rpm的搅拌12小时得到贵金属纳米颗粒/二氧化硅纳米太空舱复合材料。Step 3: Add 1 μl of silicon source TEOS to the solution obtained in Step 2, and stir at 300 rpm for 12 hours to obtain a precious metal nanoparticle/silicon dioxide nanocapsule composite material.
如图6所示为加入1-50 mM 聚丙烯酸水溶液得到的不同产物的透射电子显微镜图。结果表明,通过配体聚丙烯酸水溶液加入量的控制,可以使得二氧化硅舱的开口粒径精确可调,具体的,当配体浓度在1 mM,空心尾巴的开口尺寸大约为80 nm;当配体浓度在5mM; 空心尾巴的开口尺寸大约为120 nm;当配体浓度在10 mM, 空心尾巴的开口尺寸大约为150 nm;当配体浓度在15 mM, 空心尾巴的开口尺寸大约为180 nm;当配体浓度在20 mM,空心尾巴的开口尺寸大约为210 nm;最终合成了一系列的具有不同开口的太空舱结构。Figure 6 shows the transmission electron microscope images of different products obtained by adding 1-50 mM polyacrylic acid in water. The results show that the opening size of the silica compartment can be precisely adjusted by controlling the amount of the ligand polyacrylic acid aqueous solution added. Specifically, when the ligand concentration is 1 mM, the opening size of the hollow tail is about 80 nm; The ligand concentration is 5 mM; the opening size of the hollow tail is about 120 nm; when the ligand concentration is 10 mM, the opening size of the hollow tail is about 150 nm; when the ligand concentration is 15 mM, the opening size of the hollow tail is about 180 nm nm; when the ligand concentration was 20 mM, the size of the opening of the hollow tail was about 210 nm; finally, a series of capsule structures with different openings were synthesized.
上述实施方式为本发明的优选案例,并不用来限制本发明的保护范围。The above embodiments are preferred cases of the present invention, and are not intended to limit the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111658271.2A CN114288267A (en) | 2021-12-31 | 2021-12-31 | Noble metal nanoparticles/silica nano-space capsule composite material and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111658271.2A CN114288267A (en) | 2021-12-31 | 2021-12-31 | Noble metal nanoparticles/silica nano-space capsule composite material and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114288267A true CN114288267A (en) | 2022-04-08 |
Family
ID=80973113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111658271.2A Pending CN114288267A (en) | 2021-12-31 | 2021-12-31 | Noble metal nanoparticles/silica nano-space capsule composite material and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114288267A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009096569A1 (en) * | 2008-02-01 | 2009-08-06 | Kyushu University, National University Corporation | Method for producing metal nanomaterial and metal nanomaterial obtained by the same |
CN111872377A (en) * | 2020-07-30 | 2020-11-03 | 复旦大学 | A kind of hollow composite material and super-assembly method thereof |
-
2021
- 2021-12-31 CN CN202111658271.2A patent/CN114288267A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009096569A1 (en) * | 2008-02-01 | 2009-08-06 | Kyushu University, National University Corporation | Method for producing metal nanomaterial and metal nanomaterial obtained by the same |
CN111872377A (en) * | 2020-07-30 | 2020-11-03 | 复旦大学 | A kind of hollow composite material and super-assembly method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Feng et al. | Self‐templating approaches to hollow nanostructures | |
An et al. | Synthesis and biomedical applications of hollow nanostructures | |
CN107412195B (en) | PH-responsive antitumor drug carrier material and preparation and application thereof | |
CN102850576B (en) | Nanocomposite scaffold assembled with chitosan scaffold and its preparation method and application | |
Fang et al. | Monodisperse α-Fe2O3@ SiO2@ Au core/shell nanocomposite spheres: synthesis, characterization and properties | |
CN104550998B (en) | A kind of preparation method of gold hollow ball/cuprous nano nucleocapsid structure | |
CN106345489B (en) | A kind of sandwich structure nano catalytic material and preparation method thereof | |
CN101766923B (en) | Method for separation and redispersion of nanometer materials | |
KR102350646B1 (en) | Method of gold nanorod transformation in nanoscale confinement of zif-8 | |
CN105664936A (en) | Method for preparing nano composite material having core-shell structure with dopamine as carbon source | |
CN107335403A (en) | Load magnetic core-shell nano composite material, its preparation method and the application of nickel particle | |
CN102430375A (en) | Method for preparing silicon dioxide-silver nanometer composite microspheres | |
CN101694795B (en) | Preparation method of multi-pore canal nuclear shell type magnet gold compound nano-particle | |
CN105290393B (en) | Hollow SiO2Wrap hollow Au cages nanometer ring a bell, its preparation method and application | |
CN101433959A (en) | Method for preparing hollow nano gold powder material | |
CN105798289A (en) | Preparation method and application of carbon shell isolated noble metal nanoparticles | |
CN113209307B (en) | A kind of nano-covalent organic framework material doped with Au&Ag alloy and its preparation method and application | |
CN108236932B (en) | Superparamagnetic-plasma composite microsphere and preparation method thereof | |
Shah | Nanosynthesis Techniques of Silica-Coated | |
CN101469139B (en) | Preparation of silicon oxide supported monodisperse nanoparticle nano complex | |
Yue et al. | Deposition of gold nanoparticles on β-FeOOH nanorods for detecting melamine in aqueous solution | |
CN105056850A (en) | Method for preparing nanometer precious metal shell and magnetic core composite particle through self-assembling | |
Fan et al. | Triple function nanocomposites of porous silica-CoFe 2 O 4-MWCNTs as a carrier for pH-sensitive anti-cancer drug controlled delivery | |
CN102380620A (en) | Method for preparing magnetic metal-metal core-shell nano particles | |
CN111872377A (en) | A kind of hollow composite material and super-assembly method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220408 |